Sean Wieland
Stock Analyst at Piper Sandler
(0.86)
# 2,809
Out of 4,479 analysts
24
Total ratings
40%
Success rate
-1.35%
Average return
Main Sectors:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Upgrades: Overweight | $70 → $39 | $26.16 | +49.08% | 8 | Nov 3, 2023 | |
| AMWL American Well | Maintains: Overweight | $5 → $6 | $0.30 | +1,933.90% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $21.21 | -71.71% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $26.96 | +63.20% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $207.47 | +11.34% | 4 | Feb 18, 2022 | |
| PRVA Privia Health Group | Initiates: Overweight | n/a | $17.16 | - | 1 | May 24, 2021 | |
| TDOC Teladoc Health | Maintains: Overweight | n/a | $9.40 | - | 3 | Feb 25, 2021 | |
| ACCD Accolade | Initiates: Overweight | n/a | $3.53 | - | 1 | Jul 27, 2020 |
Omnicell
Nov 3, 2023
Upgrades: Overweight
Price Target: $70 → $39
Current: $26.16
Upside: +49.08%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $5 → $6
Current: $0.30
Upside: +1,933.90%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $21.21
Upside: -71.71%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $26.96
Upside: +63.20%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $207.47
Upside: +11.34%
Privia Health Group
May 24, 2021
Initiates: Overweight
Price Target: n/a
Current: $17.16
Upside: -
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: n/a
Current: $9.40
Upside: -
Accolade
Jul 27, 2020
Initiates: Overweight
Price Target: n/a
Current: $3.53
Upside: -